Log In
BCIQ
Print this Print this
 

Clopidogrel/acetylsalicylic acid

  Manage Alerts
Collapse Summary General Information
Company Teva Pharmaceutical Industries Ltd.
DescriptionFixed-dose combination of clopidogrel, an adenosine diphosphate (ADP) receptor antagonist, and acetylsalicylic acid
Molecular Target
Mechanism of Action 
Therapeutic ModalitySmall molecule: Combination
Latest Stage of DevelopmentRegistration
Standard IndicationAcute coronary syndrome
Indication DetailsPrevent atherothrombotic events
Regulatory Designation
Partner

 Product Details
 Archive Items are loading loading
Collapse Summary Deals Information
 Deals Details
Get a free BioCentury trial today